Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Labcorp (LH)

NYSE: LH · Health Care Services · Burlington, NC

Our rating: Neutral

Neutral reaffirmed at $355.59, moderate conviction, November 2, 2026.

Breaks if: The Neutral call turns Positive if trailing free cash flow reaches $1.7B within four reported quarters — roughly a 42% step-up from the current $1.2B — validating a genuine acceleration in earnings power that reframes the 34x multiple. It turns Cautious if revenue growth decelerates below 3% for two consecutive quarters; at this multiple, a stalling top line leaves the stock with no valuation support.

Key figures

Market value$29.8B
Revenue, last 12 months$14.6B
Net income, last 12 months$1.0B
Free cash flow, last 12 months$1.3B
Price to earnings29.7×
Free cash flow yield4.3%
Dividend yield0.8%
Operating margin10.3%
Return on equity11.4%
Beta to the S&P 5000.49
Volatility, annualized24.2%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$3.8B6.9%$3.22$412M
June 30, 2026$3.7B5.8%$3.64$314M
March 31, 2026$3.5B5.8%$3.35$71M
December 31, 2025$3.5B5.6%$1.98$490M
September 30, 2025$3.6B8.6%$3.12$281M
June 30, 2025$3.5B9.5%$2.84$543M
March 31, 2025$3.3B5.3%$2.52−$108M
December 31, 2024$3.3B9.8%$1.71$665M

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

11 ledger entries and 31 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.